Clinical Trial Update: A Study of the Pharmacokinetics and Safety of Single-dose Inhaled RJ026 in Healthy Volunteers and Patients With Interstitial Lung Disease [Phase 1]

View source ↗

Summary

This Phase 1 study examines the pharmacokinetics and safety of a single-dose inhaled RJ026 in healthy volunteers and patients with interstitial lung disease. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease

Drugs mentioned

• RJ026

Snippet

Sponsor: Ruijin Hospital | Conditions: Interstitial Lung Disease (ILD), Healthy Volunteers | Phase 1 | Status: RECRUITING